Analysis Evaluates Moore Criteria for Bevacizumab Effectiveness in Cervical Cancer February 01, 2016Vol.39 No.01
Vectibix Meets Primary Endpoint In Phase III Wild-Type KRAS Colorectal Cancer Trial February 01, 2016Vol.39 No.01
Trial of 200,000 Women Shows Screening Can Reduce Ovarian Cancer Mortality by 20 Percent February 01, 2016Vol.39 No.01
Survey of Breast Cancer Cell Function Identifies New Drug Uses, Combinations February 01, 2016Vol.39 No.01
Phase III Trial Binimetinib Increases PFS in NRAS-Mutant Melanoma vs. Dacarbazine February 01, 2016Vol.39 No.01
Phase III Melphalan Trial Shows Improvement in Hepatic-PFS in Melanoma Patients with Liver Metastases December 25, 2015Vol.38 No.12
Onivyde Combination Boosts OS in Post-Gemcitabine Pancreatic Cancer Patients December 25, 2015Vol.38 No.12
Drugs & Targets FDA Approves Opdivo Injection for Renal Cell Carcinoma Patients December 25, 2015Vol.38 No.12
AML Patients Receiving PKC412 Midostaurin Show 23% OS Improvement in Phase III Trial December 25, 2015Vol.38 No.12
Head-to-Head Phase III Study Demonstrates Kyprolis Nearly Doubles PFS over Velcade December 25, 2015Vol.38 No.12
